warnings
Warnings For external use only not intended for ingestion.
Zylotrol
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Zylotrol
- Generic name
- LIDOCAINE HCL 4%, MENTHOL 1%
- Manufacturer
- Asclemed USA, Inc.
- Product type
- HUMAN OTC DRUG
- SPL set ID
- e13984ea-73a9-2894-e053-2995a90a8ed6
- SPL ID
- 07cebfba-4f3b-882f-e063-6294a90ac460
- Version
- 3
- Effective date
- 2023-10-16
- Source export date
- 2026-10-27
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
- Import run
- 20261027T193451Z
- Imported at
- 2026-10-27 20:21:43
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M017 | openfda.application_number | |
| brand name | Zylotrol | openfda.brand_name | |
| generic name | LIDOCAINE HCL 4%, MENTHOL 1% | openfda.generic_name | |
| manufacturer name | Asclemed USA, Inc. | openfda.manufacturer_name | |
| ndc | package | 76420-145-04 | openfda.package_ndc |
| ndc | product | 76420-145 | openfda.product_ndc |
| ndc11 | package | 76420014504 | derived:openfda.package_ndc |
| rxcui | 1373137 | openfda.rxcui | |
| spl id | 07cebfba-4f3b-882f-e063-6294a90ac460 | id | |
| spl set id | e13984ea-73a9-2894-e053-2995a90a8ed6 | set_id | |
| unii | L7T10EIP3A | openfda.unii | |
| unii | V13007Z41A | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.